Company intelligence / Profile preview

Atrandi Biosciences

Vilnius, Lithuaniaatrandi.com ↗
Ownership
Private
Employees
~65
Development stage
Commercial
01

Overview

Atrandi’s SPC-based platforms enable scalable single-cell multiomic analyses with high throughput. Their products are installed in over 200 labs worldwide as of early 2025. The company has launched proof-of-concept programs demonstrating the ability to barcode up to ~10k microbial genomes per experiment at low cost ($1/cell), supporting advances in microbial community analysis and oncology diagnostics through collaborative projects.

Therapeutic areas
Oncology
Modalities
Single-cell multiomics analysis platformsMicrofluidic droplet technology for molecular and cellular analysisSemi-permeable capsule (SPC) technology for single-cell compartmentalization and genomics applicationsDNA barcoding kits for microbial genomics
Industry
Non-Drug Biotech
02

Partnerships

Collaborations with Vilnius University consortium on R&D projects such as ONCOINTEGRA (multiomics oncology), GET TOOLS (genome editing), IMMUNO (immunotherapy), HEMATO (cell therapy); partnership with Bigelow Laboratory's Single Cell Genomics Centre for bioinformatics services.

Beyond the preview

Go deeper on Atrandi Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atrandi Biosciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call